Physician profile
Stephen G Hausrath
NPI 1942218268
$1,169.77
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $242 · 2021: $15.62.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $258.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $224.50 | 2019 | |
| Glaxosmithkline, LLC. | $202.29 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $136.21 | 2019-2020 | |
| Allergan, INC. | $99.85 | 2019-2020 | |
| Lilly USA, LLC | $68.34 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $43.82 | 2019 | |
| Amarin Pharma, INC. | $34.66 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $30.23 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.35 | 2020 | |
| Abbvie INC. | $15.62 | 2021 | |
| Insmed, INC. | $15.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.65 | 2019 | |
| Pfizer INC. | $11.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hausrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.